SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-21-000050
Filing Date
2021-11-02
Accepted
2021-11-02 16:09:53
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20210930.htm   iXBRL 10-Q 1734400
2 EX-31.1 ex31110qq32021.htm EX-31.1 13059
3 EX-31.2 ex31210qq32021.htm EX-31.2 12984
4 EX-32 ex3210qq32021.htm EX-32 13891
10 halo-20210930_g1.jpg GRAPHIC 82291
11 halo-20210930_g2.jpg GRAPHIC 79812
  Complete submission text file 0001159036-21-000050.txt   8516786

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20210930.xsd EX-101.SCH 43674
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20210930_cal.xml EX-101.CAL 76411
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20210930_def.xml EX-101.DEF 248934
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20210930_lab.xml EX-101.LAB 571312
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20210930_pre.xml EX-101.PRE 413852
12 EXTRACTED XBRL INSTANCE DOCUMENT halo-20210930_htm.xml XML 1509673
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 211371392
SIC: 2836 Biological Products, (No Diagnostic Substances)